Kerwin, Edward M <br/><br/>
Indacaterol 75 μg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective.  [electronic resource] 

 -  Therapeutic advances in respiratory disease  Feb 2013 
 - 25-37 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1753-4666 
<br/><br/><label>Standard No.: </label>10.1177/1753465812470018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adrenergic beta-2 Receptor Agonists--administration & dosage<br/>Bronchodilator Agents--administration & dosage<br/>Drug Administration Schedule<br/>Humans<br/>Indans--administration & dosage<br/>Lung--drug effects<br/>North America<br/>Pulmonary Disease, Chronic Obstructive--diagnosis<br/>Quinolones--administration & dosage<br/>Severity of Illness Index<br/>Time Factors<br/>Treatment Outcome